Has received a favourable award from an extensive and comprehensive arbitration proceeding, related to a contractual dispute with Sun Pharmaceuticals Industries, Inc. regarding Sun's breach of certain provisions of its supply and distribution agreement with the Company. The contractual dispute involved Sun's launch of Absorica LD® in Canada and Sun's claim of ownership of certain clinical data. Cipher Pharmaceuticals Inc. shares T.CPH are trading up $1.08 at $15.33.
Stocks in play: Cipher Pharmaceuticals Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/AI%20(artificial%20intelligence)/Artificial%20Intelligence%20technology%20concept%20by%20NicoEINino%20via%20Shutterstock.jpg)
